Cigarette smoking is an established risk factor for cancer and cardiovascular disease, and is the leading cause of avoidable disease in most industrialized countries. Less well-known are possible beneficial effects, which are briefly considered in this survey.
Gynecological and obstetric conditions and events
Cigarette smoking has been noted to have an 'antd-estrogenic' effect, since women who smoke cigarettes behave as though they were relatively estrogen-deficient 2 ' 3 . This effect would be expected to have a beneficial impact on diseases and processes associated with estrogen excess, and several of the gynaecological and obstetric conditions that have been proposed to be inversely related to cigarette smoking are thought to be the consequence of estrogenic stimulation.
Uterine fibroids and endometriosis
In many regards, the presence of fibroids reflects estrogenic influences: women who are lean or postmenopausal have a lower prevalence of these tumours 4 -5 , although oestrogen replacement therapy has only inconsistently been related to risk 4 -6 . Available data also suggest that smoking may be inversely related to the risk of having fibroids 4 " 6 , with heavy smokers having about half the risk of never smokers, even after control for covariables such as age, body weight, and menopausal status.
Endometriosis is another disorder that seems to respond to estrogenic stimuli, and has been inversely related to cigarette smoking in several studies 7 " 9 . Initiation of the habit at an early age may be required for this effect, although the available data are insufficient to clarify this point.
Effects during pregnancy: nausea/vomiting and hypertensive disorders
Vomiting of pregnancy is the third oestrogen-related condition 10 that has been noted to be less common in smokers than in non-smokers** 10 " 13 . However, the data are not conclusive: the possibility of confounding has not been extensively considered, and adjusted relative risk estimates have not been consistently less than 1.0 14 -15 . A lower incidence of hypertensive disorders of pregnancy among smokers has been regularly found. Pre-eclampsia and eclampsia have been investigated in several studies, and a 30-50% reduction in risk has been reported among smokers'* 16 "" 21 . Although early studies did not control for confounding, this has been done in the more recent investigations, with essentially no effect on the risk estimates. Smoking during the second half of pregnancy may be the most relevant exposure 18 . Gestational hypertension is also less common among smokers than among non-smokers, although the effect is somewhat less pronounced than for pre-eclampsia/eclampsia 16 ' 18 * 22 " 24 . The mechanisms that could explain an effect of smoking on hypertensive disorders of pregnancy are not clear. Several possibilities have been proposed, including inhibition of thromboxane production, limitation of plasma volume expansion during pregnancy, and hypotensive effects of the thiocyanate contained in cigarette smoke 21 .
Dysmenorrhea Down syndrome

Neoplasia
One report that cigarette smokers have less dysmenorrhea compared with non-smokers 25 prompted speculation that inhibition of prostaglandin production might explain the reduced pain 26 . Other investigations, however, have reported no association, or (more commonly) increased dysmenorrhea among smokers'-s- . Currently, the issue remains unresolved.
Tobacco and cigarette smoke are clearly rich sources of carcinogens, and greatly increase the risk of cancer at virtually all anatomic sites having direct contact with tobacco or tobacco smoke, as well as at some sites that lack such contact 36 . There have also been suggestions that smoking might have an inverse relationship with the risk of neoplasia at some locations that do not have smoke contact-where direct carcinogenesis is not an issue, and where other effects of smoking might play a protective role.
Fibrocystic breast disease and breast cancer
Fibrocystic breast disorders are a heterogenous group of processes in the breast that appear to be responsive to ovarian hormones 37 . Several studies have suggested a lower risk among smokers, especially among currently smoking postmenopausal women 6 -38 ' 39 . The data are not consistent, however, and in other analyses no association was found 40 . A few investigations have suggested that cigarette smoking may be inversely related to the risk of breast cancer 41 . These were largely case-control studies, and subsequent investigations have reported no association or even a small increase in risk 2 ' 42 -43 . Apparently, the original reports were chance findings, or possibility the result of biasing factors in the studies themselves 44 . The considerable data available on the topic indicate that there is no substantial association, either overall, or among premenopausal or postmenopausal women considered separately 2 -42 ' 43 .
Endometrial cancer
Co/orecta/ cancer
Endometrial cancer is the only malignancy that has repeatedly been shown to be inversely related to cigarette smoking 2 ' 45 . The association is stronger among postmenopausal women, and seems to be absent in former smokers. A dose-response pattern has been found in several studies, with a relative risk of 0.5 or less among heavy smokers in comparison to never smokers. The association remains even after control for the effects of lower body weight and earlier age at menopause in smokers. In some studies, but by no means all, the association was particularly marked among women taking exogenous estrogens 2 ' 45 , a pattern consistent with the hypothesis that smoking may be acting to alter the metabolism of oral estrogens.
Some reports have suggested that cigarette smoking may be inversely related to the risk of colorectal cancer** 46 ' 47 -in particular colon cancer among women 47 . However, other epidemiological studies have not confirmed this association 48 -49 , or have reported an increased risk among long-term smokers 50 . Although the possibility of an increased risk remains controversial, the available data clearly do not suggest that smoking has an inverse association with colon cancer.
One investigation reported that among patients with ulcerative colitis, cigarette smokers had a lower risk of bowel cancer than non-smokers 51 . The association was not statistically significant, however, and the issue has not been extensively studied; the suggestion remains a speculative one.
Cardiovascular Disease
Survival after myocardial infarction
Several studies have suggested that cigarette smokers have a lower case fatality after myocardial infarction than non-smokers (reviewed in 52 ), with a reduction in fatality of 40% or greater in some reports. Several explanations for this association have been advanced, including differences between smokers and non-smokers in the types of arterial lesions that precipitate infarction, the beneficial effects of the smoking cessation enforced by hospital admission, and confounding by other prognostic factors. The last possibility is almost certainly part of the effect; strong associations between smoking and potent prognostic factors have been demonstrated 6 * 52 , and in many reports on the topic the control for confounding-even by age -has been inadequate.
Venous thrombosis
In the 1970s, there were several reports that smokers had a lower risk of deep venous thrombosis after hospital admission for myocardial infarction 53 " 55 , gynaecological surgery 56 or other reasons 57 . The relative risks that can be computed from the data presented are strikingly low: 0.25 or lower. Some later data were similar 58 , but most of these studies did not consider possible confounding, even by age. Other, often more formal, studies have failed to confirm the finding 59 " 63 . However, these negative studies have focussed on slightly different clinical events than the ones that suggested a benefit. All were conducted among women, and none focussed on in-patient venous thrombosis, as did the earlier reports. The literature regarding pulmonary embolism provides some clarification: there are no suggestions of protective effect of smoking, although the data are not extensive 64 " 66 . In many ways, an anti-thrombotic effect of cigarette smoking would seem implausible; smoking is generally thought to exert a pro-coagulant effect through increased fibrinogen levels, reduced fibrinolysis, and probably through platelet activation 67 -69 . However, there is in vitro evidence that nicotine and cotinine can inhibit synthesis of prostaglandins, including thromboxane, a potent proaggregatory prostanoid 
Inflammatory and immunological disorders
Cigarette smoking has been shown to affect several measures of immune functioning, including those of T-cell functioning and antibody response 73 . The usual concern is that this immune suppression may lead to a susceptibility to infections, although it is conceivable that the impairment could be beneficial for immunologically-mediated disorders.
An inverse association between cigarette smoking or smokeless tobacco use and the risk of recurrent aphthous ulceration of the oral mucosa has been reported in several studies, though not in alH- 74 -77 . Some investigators have also published case reports noting a worsening of the ulcers after smoking cessation, with relief after resumption'* 78 ' 79 . It has been proposed that the increased oral keratinization associated with tobacco use could explain the inverse association; the possible efficacy of nicotine chewing gum suggests that nicotine is an active moiety 80 . One study reported that another oral disorder, herpes labialis, is less prevalent in tobacco users than in non-users 81 . However, the differences were small, confounding was not considered, and the finding seems not to have been confirmed.
Ulcerative colitis
An inverse association between cigarette smoking and ulcerative colitis has been repeatedly documented. The relationship is complex, since current smokers have a markedly reduced risk relative to never smokers (as low as 0.4 or lower), but former smokers have, if anything, an increased risk 82 -83 . Reports of the amelioration of ulcerative colitis symptoms by smoking**- 84 or nicotine administration 85 ' 86 led to formal trials of transdermal nicotine. The pattern of response resembles that of corticosteroid therapy: transdermal nicotine aided the treatment of patients in relapse 87 , but a somewhat less intense nicotine regimen was ineffective in prolonging remission 88 . Thus there is considerable evidence that smoking-and nicotine in particular-has a beneficial effect in ulcerative colitis. The effect remains unexplained, although several mechanisms have been proposed, including changes in bowel mucus or prostaglandins, immune suppression, and other effects in the bowel 89 .
Extrinsic allergic alveolitis
Smoking seems clearly to be inversely related to extrinsic allergic alveolitis (farmers' lung, pigeon breeders' lung), a chronic immunologically-mediated lung disorder. Several studies have noted an inverse association of cigarette smoking with the clinical syndrome 90 
Hay fever and atopy
Sarcoidosis
A lower prevalence of hay fever was noted among smokers in one study 97 and other reports have found that smokers are less likely to react to skin prick testing with common seasonal antigens 98 " 100 . Reactions to occupational antigens, however, seem to be enhanced 100 . Aside from the need for clarification of these discrepant findings, there is at least one issue that hampers interpretation of these data: it is not clear if smoking impairs the immune response related to atopy, or if atopic individuals have difficulty even starting to smoke because of allergic symptoms.
Several case-control studies have reported an inverse association between smoking and the risk of sarcoidosis 101 " 106 . However, the control groups used by many of these investigations do not closely correspond to the cases, and it is possible that selection bias may have distorted the findings. Also, some negative reports have been published 90 -107 , and the possibility of confounding by social class has explicitly been raised 107 . The association thus remains uncertain, although the effects of smoking on lymphocyte populations make it plausible 104 ' 105 .
One study with clinic cases and general population controls reported an inverse association between cigarette smoking and severe acne 108 , a finding which has been ascribed to impaired inflammatory responses in smokers 100 . No other evidence regarding the association seems to be available.
Metabolic effects
Body weight
An inverse association between cigarette smoking and body weight is well established 109 ' 110 . The weight difference between smokers and nonsmokers appears to be larger at older ages, and is most marked for moderate smokers. Cessation of smoking is associated with weight gain, a factor which impedes smoking control efforts. Animal data support the association 110 . Several possible mechanisms have been advanced for the effects of smoking on body weight 109 -110 . Laboratory data and prospective studies suggest that smoking is associated with a decreased caloric intake, although cross-sectional investigations tend not to confirm this 110 . In any case, the effect of smoking is not completely explained by differences in energy intake or physical activity; several studies have shown that cigarette smokers have a higher metabolic rate than non-smokers 111 " 113 . Most of the weight-reducing effects of smoking seem to be due to nicotine, although there are suggestions of a behavioral component as well 113 .
Central nervous system functioning
There are several reasons why an effect of cigarette smoking or nicotine administration might plausibly have an effect on the functioning of the central nervous system. Nicotinic cholinergic receptors are widespread in the brain 114 and chronic nicotine administration increases their density 115 . Presumably as a consequence of stimulation of these receptors, nicotine leads to the release of several neurotransmittors with potentially important functional consequences 116 .
Motor system disorders: Parkinsonism and Tourette's syndrome
An inverse association between cigarette smoking and Parkinson's disease is well established 117 " 119 . Numerous epidemiological studies have confirmed the apparent protective effect, with ever smokers having a relative risk about 0.5 in comparison to never smokers. Although most of the research has involved case-control study of prevalent cases, cohort investigations and mortality studies have also supported these findings. In aggregate, the data overcome most biases that have been proposed to explain the association 117 " 119 . However, the possibility that individuals destined to be at high risk for Parkinson's disease may have an aversion to smoking has not been completely excluded.
The inverse relationship of smoking with Parkinson's disease may well reflect a genuine biological effect. Some animal studies, but not all, have shown that cigarette smoke or nicotine can ameliorate experimental Parkinsonism 120 " 123 . Also, some case reports and a more formal doubleblind trial have suggested a benefit of nicotine administration in patients with Parkinsonism 124 ' 125 . Moreover, nicotine appears to effect several disorders of the extrapyramidal motor system in addition to Parkinson's disease: smoking or nicotine can reduce drug-induced Parkinsonism, ameliorate Tourette's syndrome, and worsen neuroleptic tardive dyskinesia, effects that all point to effects on dopaminergic motor systems 119 -126 .
Alzheimer's disease
The epidemiological data regarding a possible inverse association between cigarette smoking and Alzheimer's dementia is fairly consistent; most studies have reported an inverse association, although there are reports to the contrary 118 -127 - 128 . As for Parkinson's disease, much of the research involves case-control studies with prevalent cases. Alzheimer's epidemiology is complicated by the difficulties of distinguishing Alzheimer's dementia from other dementing illnesses, and (in casecontrol research) by the need for surrogate respondents. However, the plausibility of a protective effect of smoking on Alzheimer's disease is supported by reports that short-term nicotine administration may provide modest improvements in measures of mental functioning in patients with Alzheimer's disease 129 ' 130 .
Mental functioning
In addition to effects in Parkinson's disease and Alzheimer's dementia, smoking may also effect mental performance in non-diseased individuals. Research conducted among smokers has shown that cigarette smoking (or nicotine administration) has several benefits, including modest improvements in vigilance and information processing, facilitation of some motor responses, and perhaps enhancement of memory 131 " 133 . Also, smoking or nicotine clearly ameliorates the mild deterioration in mental functioning associated with nicotine withdrawal. The effects of nicotine in non-smokers are not as clear. The use of smokers in much of the cognitive research has necessarily involved individuals with chronic nicotine exposure; this may well alter acute affects through tolerance or receptor changes, or through the distortions associated with nicotine withdrawal. Nonetheless, there are certainly data suggesting benefits of nicotine in non-smokers with regard to performance and information processing 131 " 135 . Consistent with these findings, experimental studies in animals have suggested that nicotine may improve learning and memory, although some investigations showed evidence of nicotine-associated impairments 132 .
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Mechanisms
Conclusions
A variety of mechanisms have been invoked to explain the relationships described. Several of the proposed beneficial effects involve disorders that are associated with estrogen-excess (endometrial cancer, uterine fibroids, endometriosis, fibrocystic breast disease). The anti-estrogenic effect is itself unexplained, but may involve induced changes in the metabolism of estrogens, direct toxic effects on ovarian follicles, or interference with pituitary regulation of sex hormone systems 2 . A second group of possible benefits involves the effects of smoking on central nervous system neurotransmitter systems 116 . These effects could plausibly explain associations of smoking with Parkinson's disease, Alzheimer's dementia, and mental functioning. Third, there are clear indications that smoking can alter prostaglandin pathways, and suppress at least some aspects of immunological functioning 68 ' 73 . These effects could underlie the associations of smoking with ulcerative colitis, farmers' lung and hypertensive disorders of pregnancy.
These benefits are not without their costs, however. The antiestrogenic effect of smoking may at least partially explain the association of smoking with an increased risk of osteoporotic fractures 2 and the central nervous system effects of nicotine clearly underlie tobacco dependence 109 . Inhibition of prostaglandin synthesis is thought to play a role in the effects of smoking on vascular disease 67 .
Some of the proposed beneficial effects of smoking are not real. The effect of smoking on survival after myocardial infarction is at least partly artifactual, and smokers do not have a lower risk of dysmenorrhoea, colorectal cancer, and breast cancer as has been suggested. For effects on Down syndrome and venous thrombosis, the available data are not sufficient for conclusions to be drawn, and the association remains speculative; no convincing mechanisms have been proposed. For other conditions, possible benefits are more plausible, but remain unproven. These include functionally important improvements in mental functioning and Alzheimer's dementia, and inverse associations with sarcoidosis. Finally, the available evidence is very suggestive of a genuine benefit with regard to endometrial cancer, aphthous ulcers, ulcerative colitis, external allergic alveolitis, Parkinson's disease, and control of body weight. These associations can hardly be used to justify cigarette smoking; its adverse effects are simply too overwhelming. However, these data do provide insight into the mechanisms of several diseases, and suggest avenues for treatments and preventive measures that are likely to be far safer than cigarette smoking.
